TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
PBLS

Parabilis Medicines, Inc.

Healthcare · Biotechnology

32.60$ +4.4% vs. previous close Closing price · As of: Sep 28, 2026

Investor relations

Report Dates

Investor relations overview for Parabilis Medicines, Inc. (PBLS): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/12/2026.

Next report 11/12/2026
Last report 08/13/2026
Earnings surprise by quarter (%)
Q2 26 · -1,231.3 % 26

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 09/15/2026 Parabilis Medicines, Inc. (PBLS): Regulation FD Disclosure · sec.gov Open ↗
  • 09/02/2026 Parabilis Medicines, Inc. (PBLS): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers · sec.gov Open ↗
  • 08/25/2026 Parabilis Medicines, Inc. (PBLS): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/13/2026 Parabilis Medicines, Inc. (PBLS): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?